Cargando…
Mitochondrial-Targeting Anticancer Agent Conjugates and Nanocarrier Systems for Cancer Treatment
The mitochondrion is an important intracellular organelle for drug targeting due to its key roles and functions in cellular proliferation and death. In the last few decades, several studies have revealed mitochondrial functions, attracting the focus of many researchers to work in this field over nuc...
Autores principales: | Battogtokh, Gantumur, Cho, Yong-Yeon, Lee, Joo Young, Lee, Hye Suk, Kang, Han Chang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107715/ https://www.ncbi.nlm.nih.gov/pubmed/30174604 http://dx.doi.org/10.3389/fphar.2018.00922 |
Ejemplares similares
-
Mitochondria-targeting drug conjugates for cytotoxic, anti-oxidizing and sensing purposes: current strategies and future perspectives
por: Battogtokh, Gantumur, et al.
Publicado: (2018) -
Photo-Functionalized Magnetic Nanoparticles as a Nanocarrier of Photodynamic Anticancer Agent for Biomedical Theragnostics
por: Nam, Ki Chang, et al.
Publicado: (2020) -
Urokinase receptor and resistance to targeted anticancer agents
por: Gonias, Steven L., et al.
Publicado: (2015) -
Sustaining Intravitreal Residence With L-Arginine Peptide-Conjugated Nanocarriers
por: Li, Hao, et al.
Publicado: (2017) -
Editorial: Protein-based nanocarriers for delivery of nutraceutical, diagnostic and therapeutic agents
por: Zhong, Jian, et al.
Publicado: (2022)